206269-27-4

Usage

Uses

1. Used in Pharmaceutical Applications:
1-[(2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide is used as a pharmaceutical compound for its potential immunomodulatory and therapeutic properties. The specific application reason is due to its structural features that may allow it to interact with biological targets and modulate immune responses.
2. Used in Drug Delivery Systems:
In the field of drug delivery, 1-[(2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide may be utilized as a component in the design of novel drug delivery systems. Its unique structure could be exploited to enhance the delivery, bioavailability, and therapeutic outcomes of various drugs, particularly in the context of targeted therapies.
3. Used in Chemical Synthesis:
1-[(2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide can also be used as a synthetic building block in the development of new chemical entities. Its versatile structure may serve as a starting point for the synthesis of various bioactive molecules, potentially leading to the discovery of new drugs and therapeutic agents.

InChI:InChI=1/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m0/s1

Upstream product

• 144490-03-9 1,2,3,5-tetra-O-acetyl-β-L-ribofuranose 
• 41546-21-8 L-ribose 
• 206269-26-3 methyl 1-(2,3,5-tri-O-acetyl-β-L-ribofuranosyl)-1,2,4-triazole-3-carboxylate 

Downstream Products

• 705929-70-0 1-(6S-hydroxymethyl-2-phenyl-tetrahydro-3aS,6aS-furo[3,4-d][1,3]dioxol-4S-yl)-1H-[1,2,4]triazole-3-carboxylic acid amide 
• 705930-01-4 2S-benzyloxycarbonylamino-3-methyl-butyric acid 5S-(3-carbamoyl-[1,2,4]triazol-1-yl)-3R,4S-dihydroxy-tetrahydro-furan-2S-ylmethyl ester 
• 263708-22-1 1-[2-O-phenylthioformate-3,5-O-(1,1,3,3-tetraisopropyl-1,3-O-disiloxanyl)-β-L-ribofuranosyl]-1,2,4-triazole-3-carboxamide 

Relevant academic research and scientific papers

Monocyclic L-nucleosides, analogs and uses thereof

Novel monocyclic L- nucleoside compounds have general formula (I). Embodiments of these compounds are contemplated to be useful in treating a wide variety of diseases including infections, infestations, neoplasms, and autoimmune diseases. Viewed in terms of mechanism, embodiments of the novel compounds show immunomodulatory activity, and are expected to be useful in modulating the cytokine pattern, including modulation of Th 1 and Th 2 response.

Monocyclic L-nucleosides with type 1 cytokine-inducing activity

A series of 1,2,4-triazole L-nucleosides were synthesized and evaluated for their ability to stimulate type i cytokine production by activated human T cells in direct comparison to the known active agent ribavirin. Among the compounds prepared, 1-β-L-ribofuranosyl-1,2,4-triazole-3-carboxamide (5, ICN 17261) was found to be the most uniformly potent compound. Conversion of the 3-carboxamide group of 5 to a carboxamidine functionality resulted in 1-β-L- ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride (10), which induced cytokine levels comparable to 5 for two of the three type 1 cytokines examined. Modification of the carbohydrate moiety of 5 provided compounds of reduced activity. Significantly, ICN 17261 offers interesting immunomodulatory potential for the treatment of diseases where type I cytokines play an important role.

Monocyclic L-Nucleosides, analogs and uses thereof

Novel monocyclic L-Nucleoside compounds have the general formula STR1 Embodiments of these compounds are contemplated to be useful in treating a wide variety of diseases including infections, infestations, neoplasms, and autoimmune diseases. Viewed in terms of mechanism, embodiments of the novel compounds show immunomodulatory activity, and are expected to be useful in modulating the cytokine pattern, including modulation of Th1 and Th2 response.